HB Wealth Management »

Candel Therapeutics shares owned by HB Wealth Management

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by HB Wealth Management from 13F filings

Historical chart of HB Wealth Management investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by HB Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by HB Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $298k 58k 5.10
2025-03-31 $533k 94k 5.65
2024-12-31 $696k 87k 7.97
2024-09-30 $393k 57k 6.93

More positions owned by HB Wealth Management

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
American Centy Etf Tr Us Eqt Etf (AVUS)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Apple Put Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr S&p 500 Grwt Etf (IVW)
Home Depot (HD)
Microsoft Corporation Put Option (MSFT)
NVIDIA Corporation Put Option (NVDA)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)

View all positions for HB Wealth Management

Top funds holding Candel Therapeutics

FMR
Acorn Capital Advisors
BlackRock
Vanguard Group
Portolan Capital Management
Geode Capital Management
Halter Ferguson Financial
State Street Corporation
Citadel Advisors
Sands Capital Ventures
Susquehanna International
Northern Trust
Nuveen
Tanager Wealth Management
Wellington Management Company

View all funds holding Candel Therapeutics